Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Frontera London

- PMLiVE

First-line ovarian approval cements AZ’s Lynparza lead

Also new data on recently approved kidney disease drug

- PMLiVE

Post-Brexit immigration policy has a critical missing piece

ABPI welcomes focus on skills, but UK must respond fast to skills gaps

- PMLiVE

Optimum expands comms offering to Switzerland

Leti McManus will work with firm on IR, corporate and financial comms

- PMLiVE

WPP to cut 3,500 jobs in major restructuring

Firm says it will invest in creativity, tech and talent

- PMLiVE

GSK and Pfizer to create combined consumer health titan

Spin-out will allow GSK to focus on prescription drugs and vaccines

- PMLiVE

Fishawack acquires creative consultancy Blue Latitude Health

The Fishawack Group has acquired Blue Latitude Health, based in London, UK, and New York, USA. Blue Latitude Health is a creative consultancy combining the commercial focus of a consultancy...

Avalere Health

- PMLiVE

Business warning as talk of Brexit ‘No deal’ grows

'Managed no deal' plan is 'not a credible position' warns business

- PMLiVE

China first market to approve AZ’s kidney drug roxadustat

A milestone for China and AZ and partners FibroGen

Season’s Greetings

Do you have Tinsilitus?

Cuttsy + Cuttsy

Lucid Winter Meeting 2018

The teams gathered at The Artisan in Clerkenwell, London, to reflect on the year and celebrate both team and individual contributions to Lucid, their clients and the local community through...

Lucid Group Communications Limited

2018 was a magical year for Lucid Group, filled with memorable moments and many celebrations

This year has been a ground-breaking year for Lucid Group, punctuated by magical makeovers, plenty of awards, landmark staff celebrations and worthwhile charity work.The tone of the year was set...

Lucid Group Communications Limited

- PMLiVE

Horizon Discovery and C4X to harness CRISPR for new cancer drugs

UK companies combine computational and genomic platforms

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links